{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:02:13Z","timestamp":1780923733478,"version":"3.54.1"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.resmer.2026.101268","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:17:25Z","timestamp":1774883845000},"page":"101268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Chalazion and hordeolum associated with Elexacaftor-Tezacaftor-Ivacaftor use in children with cystic fibrosis"],"prefix":"10.1016","volume":"89","author":[{"given":"Christy","family":"Liew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Brookes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Wisby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J","family":"Mayell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7662-2725","authenticated-orcid":false,"given":"Tim WR","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.resmer.2026.101268_bib0001","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/11206721251330146","article-title":"Management strategies for chalazia in pediatric patients: a scoping review","volume":"35","author":"Kornhauser","year":"2025","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"10.1016\/j.resmer.2026.101268_bib0002","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ophtha.2024.12.035","article-title":"Chalazion and hordeolum development in patients with cystic fibrosis on Elexacaftor\/Tezacaftor\/Ivacaftor therapy","volume":"132","author":"Kates","year":"2025","journal-title":"Ophthalmology"},{"issue":"2025","key":"10.1016\/j.resmer.2026.101268_bib0003","article-title":"Chalazion and hordeolum in paediatric patients with cystic fibrosis on Elexacaftor\/Tezacaftor\/Ivacaftor","author":"Lieu","year":"2025","journal-title":"Paediatr Respir Rev"},{"issue":"12","key":"10.1016\/j.resmer.2026.101268_bib0004","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.3390\/ijms25126692","article-title":"Ocular changes in cystic fibrosis: a review","volume":"25","author":"Liberski","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.resmer.2026.101268_bib0005","series-title":"Vertex Pharmaceuticals Incorporated","year":"2025"},{"issue":"10","key":"10.1016\/j.resmer.2026.101268_bib0006","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1164\/rccm.202411-2231OC","article-title":"Long term safety and efficacy of Elexacaftor\/Tezacaftor\/Ivacaftor in adults and adolescents with cystic fibrosis and at least one F508del Allele","volume":"211","author":"Daines","year":"2025","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259004122600022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259004122600022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:13:31Z","timestamp":1780920811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259004122600022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":6,"alternative-id":["S259004122600022X"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2026.101268","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chalazion and hordeolum associated with Elexacaftor-Tezacaftor-Ivacaftor use in children with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2026.101268","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 SPLF and Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101268"}}